Powered by
-
ABT Stock Chart
Historical ABT Prices
Abbott Laboratories Stock Analysis
Rating: Buy
Total Grade: B
Analysis Breakdown
| ABT Stock Grade: | B |
| Fundamental Grade: | C |
| Quantitative Grade: | B |
| ABT Earnings | |
| Earnings Growth: | C |
| Earnings Momentum: | A |
| Earnings Surprises: | C |
| Analyst Earnings Revisions: | C |
| ABT Financial Information | |
| Sales Growth: | B |
| Operating Margin Growth: | C |
| Cash Flow: | C |
| Return on Equity: | D |
Abbott Laboratories Stock: Weekly View
| This Week: | B |
|---|---|
| Last Week: | B |
| Two Weeks Ago: | B |
ABT Stock predictions, Articles, and Abbott Laboratories News
- From InvestorPlace
- From the Web
-
Abbott Laboratories Stock Slips Despite Earnings Beat - April 18, 2018
Abbott Laboratories (ABT) stock as down on Wednesday despite the health care company reporting an earnings beat for the first quarter of 2018. Continue…
-
10 Dividend Aristocrats You Never Have to Worry About - April 9, 2018
There are dividend stocks, and then there are dividend stocks. These ten names are the income producers you rarely have to worry about. Continue…
-
At $ 59.460, Abbott Laboratories (ABT) a Buy - March 8, 2018
The Buy for Abbott Laboratories (ABT) this week is based on the latest relative pricing of its shares and market intelligence. Continue…
-
Abbott Laboratories (ABT) a Buy This Week - March 2, 2018
The Buy for Abbott Laboratories (ABT) this week is based on the latest relative pricing of its shares and news. Continue…
-
5 Cheap Dividend Stocks With Growing Payouts - February 15, 2018
With interest rates still low and the market possibly overvalued, cheap dividend stocks are a good choice for retirement and income investors. Continue…
-
7 ‘Strong Buy’ Stocks That Look Cheap Right Now - February 14, 2018
With recent market fluctuations, these 7 stocks now make particularly compelling investing opportunities -- and each boasts a Street consensus rating of 'Strong Buy.' Continue…
-
Abbott Laboratories (ABT) a Buy at recent price of $63.22, on Robust Earnings Momentum - January 26, 2018
Portfolio Grader currently ranks ABT as a Buy. This analytical tool evaluates stocks by employing proprietary fundamental and quantitative analytical. This represents no change from the previous week and is the same ranking ABT has had from Portfolio Grader for 4 months. Continue…
-
5 Soaring ‘Strong Buy’ Stocks Ahead of Earnings Season - January 16, 2018
Here are five stellar stocks to keep a close eye on as we head deeper into earnings season. All these stocks are due to report earnings in the next couple of weeks. You can feel good about these stock picks as each of these five stocks has a 'Strong Buy' consensus rating from the Street's best-performing analysts. Continue…
-
3 of the Best Dividend Aristocrats for Retirement - January 12, 2018
Dividend Aristocrats are some of the most reliable dividend stocks out there. But these specific "aristocrats" offer both growth and income. Continue…
-
AbbVie Inc Dividend at Risk Amid Patent Protection Problems - December 29, 2017
ABBV remains a strong holding for dividend growth, but AbbVie is about to lose patent protection on Humira, which accounts for two-thirds of its revenue. Continue…
